TRADING QUOTES 4:02 PM December 10, 2023
IPO Terms Details
Business Combination
Related Articles
SEC Filings
SPAC Name : Brookline Capital Acquisition Corporation *
| Total Public Proceeds at IPO($mm): | 57.5 |
| %Held in Trust: | 101.0 |
| $Held in Trust per Unit: | $ 10.10 |
| Mgmt's Sector Expertise/Focus: | BioTech |
| IPO Date: | 2021-01-29 |
| Months to Complete: | 15 |
| Deadline Date: | 2022-08-02 |
| Unit Structure (BCACU) | |
| Share (BCAC): | 1 Share of Common Stock |
| Warrant (BCACW) | 1/2 Warrant |
| Right() | |
| Public Warrant Terms: | |
| Exercise Price: | 11.500000000 |
| Redemption Price: | Cash/Cashless: $18.00 |
| Redemption: Cash, Cashless or for Shares | Mgmt's Discretion |
| Underwriters: | |
| Book-runner(s): | Ladenburg Thalmann |
| Co-Manager(s): | |
| Fees (Upfront/Deferred): | 1.5%/--- |
| Lawyers: | |
| Issuer's Counsel: | Ellenoff Grossman & Schole LLP |
| Underwriter's Counsel: | Graubard Miller |
| Additional Terms: | Crescent Term: $9.20 threshold, Limitation on redemption rights: 15% |
SPAC Name: Brookline Capital Acquisition Corporation *
| CURRENT FUNDS in TRUST: | $51,725,409* |
| EST. PRO RATA AMOUNT IN TRUST: | $10.22* |
| IMPLIED ENTERPRISE VALUE: | $151.9 million |
| RECORD DATE: | 2022-06-27 |
| SHAREHOLDER VOTE DATE: | 2022-07-27 |
| SPAC NameSource: SEC.gov filings and SPAC Insider estimates | |
|---|---|
TRADING QUOTES Business CombinationIPO Terms Details SPAC name: %spacname% CURRENT FUNDS in TRUST: $%ending_trust_ball%* EST. PRO RATA AMOUNT IN TRUST: $%implied_cash_per_share%* IMPLIED ENTERPRISE VALUE: %impliedenterprisevalue% RECORD DATE: %businesscombinationrecorddate% SHAREHOLDER VOTE DATE: %businesscombinationshareholdervotedate% Source: SEC.gov filings and SPAC Insider estimates SPAC name: %spacname% Total Public Proceeds at IPO ($mm): %total% % Held in Trust:
Read More
Read More